by Jessica Casebolt | Mar 16, 2023 | D.C. News, Tea Leaves
A new staff report from the Food and Drug Administration (FDA) says that Pfizer’s antiviral COVID-19 treatment, Paxlovid, is safe and effective at treating adults with mild to moderate COVID-19 who are at high risk of progressing to severe disease, including...
by Jessica Casebolt | Mar 16, 2023 | Access & Coverage, Tea Leaves
The judge in a closely watched lawsuit seeking to overturn federal approval of a widely used abortion pill questioned lawyers publicly for the first time yesterday. The wide-ranging hearing included discussion about whether the anti-abortion plaintiffs had the legal...
by Jessica Casebolt | Mar 15, 2023 | Public Health/Prevention, Tea Leaves
The US Environmental Protection Agency proposed the first national drinking water standard for “forever chemicals” that are dangerous to human health. The move could radically affect drinking water for nearly everyone in the United States. The new rule intends to set...
by Jessica Casebolt | Mar 15, 2023 | Opioid/Substance Use Disorders, Tea Leaves
The Office of National Drug Control Policy released the Model Substance Use Disorder Treatment In Emergency Settings Act for the purpose of establishing and aligning mechanisms for maximizing emergency medical settings as intervention points for people who experience...
by Jessica Casebolt | Mar 15, 2023 | D.C. News, Tea Leaves
The Biden administration will fine manufacturers who hiked prices for 27 medicines faster than the rate of inflation. Pfizer had five drugs on the list, the most of any manufacturer. AbbVie’s blockbuster arthritis drug, Humira, was also on the list. Officials said the...
Recent Comments